AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Enblok 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Nebivolol (2.5mg)

Overview Enblok 2.5mg Tablet

Cardiogard 2.5mg tablets are classified as beta-adrenergic blocking agents. This medication is indicated for the management of hypertension. It also offers preventative benefits against myocardial infarction and cerebrovascular accidents. Cardiogard 2.5mg tablets are additionally prescribed to alleviate hyperthyroidism symptoms. Administration may be independent or adjunctive to other therapies, with dosage and frequency determined by the specific indication and disease severity. It can be ingested with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic effects may take several weeks to manifest, and continuous use might be necessary. Consistent medication adherence is paramount, even during asymptomatic periods, as discontinuation can exacerbate the underlying condition. Complementary lifestyle modifications, including a low-fat diet, regular physical activity, and smoking cessation, augment treatment success. Common adverse effects, typically mild and transient, include lassitude, cephalalgia, vertigo, dyspnea, nausea, and edema. Hypotension and respiratory compromise are potential, albeit less frequent, side effects. Gradual dose escalation, beginning with a low dose, minimizes adverse event risk. Consult your physician concerning persistent or bothersome side effects. Prior to initiating therapy, disclose any hepatic dysfunction to your healthcare provider. This medication may be contraindicated in individuals with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals require medical consultation before commencing treatment. A physician's evaluation is essential to determine suitability. Regular blood pressure monitoring ensures treatment effectiveness. Alcohol consumption should be avoided due to the potential for amplified adverse reactions.

Uses of Enblok 2.5mg Tablet

Managing high blood pressure | Reducing heart attack risk | Preventing strokes

Major Benefits of Enblok 2.5mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Enblok 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended for optimal results.

Common Side effects of Enblok 2.5mg Tablet:

  • Nausea
  • Headache
  • Fatigue
  • Constipation
  • Diarrhea
  • Dizziness
  • Breathlessness
  • Edema (swelling)

How to use Enblok 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Enblok 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended.

How Enblok 2.5mg Tablet works:

Cardioslow 2.5mg tablets are a cardioselective beta-blocker targeting the heart. Their mechanism reduces heart rate and promotes vasodilation, thereby improving the heart's pumping efficiency.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Using Enblok 2.5mg Tablets with alcohol requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Enblok 2.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Enblok 2.5mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Enblok 2.5mg Tablets might cause drowsiness, blurred vision, or dizziness. Driving is inadvisable if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Enblok 2.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Enblok 2.5mg tablets cautiously, potentially requiring dosage modification. Consult a physician. Enblok 2.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Enblok 2.5mg Tablet :

Should you forget a dose of your Enblok 2.5mg Tablet, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Enblok 2.5mg Tablet

LabelValue
Type of Compound Chromane derivative
Potential for Dependence None.
Type of Medication HEART
Mechanism of Action Selective beta-adrenergic blocking agent

FAQs on Enblok 2.5mg Tablet

Your blood pressure might begin to lower within one to two weeks of commencing Enblok 2.5mg Tablet therapy; complete effectiveness may require up to four weeks.
Discontinuing Enblok 2.5mg Tablet prematurely, even with symptom improvement, is inadvisable. This medication manages, but doesn't eliminate, high blood pressure. Abrupt cessation increases the risk of angina, myocardial infarction, or arrhythmia. Consult your physician; they may recommend a phased reduction in dosage over one to two weeks.
Exceeding the prescribed dosage of Enblok 2.5mg Tablets can result in bradycardia, hypotension potentially leading to syncope, dyspnea, and acute cardiac insufficiency. Should an overdose of Enblok 2.5mg Tablets occur, seek immediate medical attention.
Concurrent use of ibuprofen and Enblok 2.5mg tablets necessitates close blood pressure monitoring. Ibuprofen can impair the efficacy of Enblok 2.5mg tablets, potentially elevating blood pressure. Conversely, ceasing ibuprofen after prolonged use may lower blood pressure.
Enblok 2.5mg tablets do not influence blood glucose concentrations. Nevertheless, continued monitoring of blood sugar is advised, as Enblok 2.5mg tablet use can obscure symptoms of hypoglycemia, such as tachycardia and palpitations.
Enblok 2.5mg tablets may be prescribed for patients aged 65 and older, however, only under strict medical supervision. For this demographic, physicians typically initiate treatment with the minimum effective dose, incrementally adjusting it as needed. Patients 75 years or older necessitate vigilant blood pressure monitoring.
Enblok 2.5mg Tablets are not known to induce weight increase. However, if you gain weight while using Enblok 2.5mg Tablets, consult your physician as this may be unrelated to the medication.
Enblok 2.5mg Tablets readily penetrate the blood-brain barrier owing to their lipid solubility. This lipid solubility facilitates interaction with lipids and fats, enabling efficacy in managing migraine and essential tremor. However, this property may increase the likelihood of central nervous system side effects, including drowsiness, cognitive impairment, and depressive symptoms.
The use of Enblok 2.5mg Tablets is contraindicated during pregnancy due to its potential to reduce fetal blood flow. This reduction can cause fetal demise, growth retardation, and may precipitate miscarriage or premature birth. Pregnant patients currently taking Enblok 2.5mg Tablets should immediately notify their physician for alternative treatment.
Enblok 2.5mg tablets can induce tiredness and dizziness. Exercise caution when operating machinery or vehicles. Consult your physician if these side effects occur during treatment with Enblok 2.5mg tablets.
Enblok 2.5mg Tablet
37
MRP 44
14% off